Angiopoietin-1 (ANGPT1) Antibody

Este producto es parte de ANGPT - Angiopoietin
Product Graph
221€ (50 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Angiopoietin-1 (ANGPT1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx330144
tested applications
ELISA, WB

Description

ANGPT1 Antibody is a Rabbit Polyclonal against ANGPT1.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Angiopoietin-1 (ANGPT1)
Host
Rabbit
Reactivity
Human, Rat
Recommended Dilution
ELISA: 1/20000, WB: 1/500 - 1/2000. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Purified by affinity chromatography.
Size 1
50 µg
Size 2
100 µg
Form
Liquid
Tested Applications
ELISA, WB
Buffer
PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q15389
Gene ID
284
Alias
AGP1,AGPT,ANG1,HAE5,AGPT-1
Background
Antibody anti-ANGPT1
Status
RUO

Descripción

ANGPT1 is a secreted glycoprotein that plays a critical role in angiogenesis, the process of new blood vessel formation, and the stabilization of vascular networks. ANGPT1 binds to and activates the Tie2 receptor, a tyrosine kinase expressed on endothelial cells, leading to signaling pathways that promote endothelial cell survival, migration, and the formation of stable, mature blood vessels. ANGPT1 is essential for maintaining vascular integrity and preventing vascular leakage by enhancing cell-cell junctions and stabilizing endothelial barriers. It also counteracts pro-inflammatory signals and prevents excessive vascular permeability caused by VEGF or other stressors. ANGPT1 is involved in developmental processes such as embryonic vascular formation and tissue regeneration. Dysregulation of ANGPT1 has been implicated in vascular disorders, including chronic inflammation, edema, and cardiovascular diseases. ANGPT1’s role in maintaining vascular stability makes it a therapeutic target for diseases involving abnormal angiogenesis, such as cancer, diabetic retinopathy, and sepsis.

Related Products

EH0035

Human ANG1 (Angiopoietin-1) ELISA Kit

Ver Producto
EM0016

Mouse Ang1 (Angiopoietin-1) ELISA Kit

Ver Producto
EP0202

Porcine ANG1 (Angiopoietin-1) ELISA Kit

Ver Producto